Dennis Slamon - Net Worth and Insider Trading

Dennis Slamon Net Worth

The estimated net worth of Dennis Slamon is at least $1 Million dollars as of 2024-11-13. Dennis Slamon is the Director of Biomarin Pharmaceutical Inc and owns about 21,639 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $1 Million. Details can be seen in Dennis Slamon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Slamon has not made any transactions after 2022-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dennis Slamon

To

Dennis Slamon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dennis Slamon owns 1 companies in total, including Biomarin Pharmaceutical Inc (BMRN) .

Click here to see the complete history of Dennis Slamon’s form 4 insider trades.

Insider Ownership Summary of Dennis Slamon

Ticker Comapny Transaction Date Type of Owner
BMRN Biomarin Pharmaceutical Inc 2022-02-28 director

Dennis Slamon Latest Holdings Summary

Dennis Slamon currently owns a total of 1 stock. Dennis Slamon owns 21,639 shares of Biomarin Pharmaceutical Inc (BMRN) as of February 28, 2022, with a value of $1 Million.

Latest Holdings of Dennis Slamon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMRN Biomarin Pharmaceutical Inc 2022-02-28 21,639 66.12 1,430,771

Holding Weightings of Dennis Slamon


Dennis Slamon Form 4 Trading Tracker

According to the SEC Form 4 filings, Dennis Slamon has made a total of 1 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 6,396 shares on February 28, 2022, which brought Dennis Slamon around $500,999.

Insider Trading History of Dennis Slamon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dennis Slamon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dennis Slamon Ownership Network

Ownership Network List of Dennis Slamon

No Data

Ownership Network Relation of Dennis Slamon

Insider Network Chart

Dennis Slamon Owned Company Details

What does Biomarin Pharmaceutical Inc do?

Who are the key executives at Biomarin Pharmaceutical Inc?

Dennis Slamon is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include GVP & Chief Accounting Officer Erin Burkhart , EVP & Chief Financial Officer Brian Mueller , and VP & General Counsel George Eric Davis .

Biomarin Pharmaceutical Inc (BMRN) Insider Trades Summary

Over the past 18 months, Dennis Slamon made no insider transaction in Biomarin Pharmaceutical Inc (BMRN). Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 153,000 shares made by Jean Jacques Bienaime , a net sale of 92,066 shares made by George Eric Davis , and a net sale of 14,000 shares made by Jeffrey Robert Ajer .

In summary, during the past 3 months, insiders sold 0 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 319,767 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 319,767 shares.

Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biomarin Pharmaceutical Inc Insider Transactions

No Available Data

Dennis Slamon Mailing Address

Above is the net worth, insider trading, and ownership report for Dennis Slamon. You might contact Dennis Slamon via mailing address: 770 Lindaro Street, San Rafael Ca 94901.